References
- Thursz M, Kamath PS, Mathurin P, et al. Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study. J Hepatol. 2019;70(3):521–530.
- Verrill C, Markham H, Templeton A, et al. Alcohol-related cirrhosis–early abstinence is a key factor in prognosis, even in the most severe cases. Addiction. 2009;104(5):768–774.
- Jepsen P, Ott P, Andersen PK, et al. The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia–a historical cohort study. BMC Res Notes. 2012;5:509.
- Rodríguez M, González-Diéguez ML, Varela M, et al. Impact of alcohol abstinence on the risk of hepatocellular carcinoma in patients With Alcohol-Related liver cirrhosis. Am J Gastroenterol. 2021;116(12):2390–2398.
- Schmidt M, Schmidt SA, Sandegaard JL, et al. The danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
- Gjerstorff ML. The danish cancer registry. Scand J Public Health. 2011;39(7 Suppl):42–45.
- Helweg-Larsen K. The danish register of causes of death. Scand J Public Health. 2011;39(7 Suppl):26–29.
- Langholz B, Goldstein L. Risk set sampling in epidemiologic cohort studies. Statist Sci. 1996;11(1):35–53.
- Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158(16):1789–1795.
- Bradley KA, DeBenedetti AF, Volk RJ, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208–1217.
- Thompson WA.Jr. On the treatment of grouped observations in life studies. Biometrics. 1977;33(3):463–470.
- Austin PC, Fine JP. Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017;36(27):4391–4400.
- Jepsen P, Vilstrup H, Andersen PK. The clinical course of cirrhosis: the importance of multistate models and competing risks analysis. Hepatology. 2015;62(1):292–302.
- Lambert PC. The estimation and modelling of cause-specific cumulative incidence functions using time-dependent weights. Stata J. 2017;17(1):181–207.
- Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328(25):1797–1801.
- Adami HO, Hsing AW, McLaughlin JK, et al. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer. 1992;51(6):898–902.
- Abassa KK, Wu XY, Xiao XP, et al. Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study. BMC Gastroenterol. 2022;22(1):130.
- Storm HH, Michelsen EV, Clemmensen IH, et al. The danish cancer registry–history, content, quality and use. Dan Med Bull. 1997;44(5):535–539.
- Jepsen P, Kraglund F, West J, et al. Risk of hepatocellular carcinoma in danish outpatients with alcohol-related cirrhosis. J Hepatol. 2020;73(5):1030–1036.
- Farrell C, Halpen A, Cross TJS, et al. Ultrasound surveillance for hepatocellular carcinoma: service evaluation of a radiology-led recall system in a tertiary-referral Centre for liver diseases in the UK. Clin Radiol. 2017;72(4):338.e11–e17.
- Davila JA, Henderson L, Kramer JR, et al. Utilization of surveillance for hepatocellular carcinoma Among hepatitis C virus–infected veterans in the United States. Ann Intern Med. 2011;154(2):85–93.
- Henrion J, Libon E, De Maeght S, et al. Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients. Acta Gastro Enterolog Belgica. 2000;63(1):5–9.